Saturday, December 6, 2025

Novo Nordisk and Lilly Block Generics, Tighten Grip on $125B GLP-1 Market

Novo Nordisk and Eli Lilly secure court victories against generics, maintaining dominance in the GLP-1 treatment market amid rising demand.

UN General Assembly Hosts Rare Debate on North Korea’s Human Rights Violations

The UN's first high-level meeting on North Korean human rights, with South Korean participation, spotlighted systemic violations and global concerns.

K-Pop’s Next Big Thing: BabyMonster Begins Music Video Shoot for Their Debut Album!

K-pop group BabyMonster has begun filming multiple music videos for their debut album, set for release this fall.

Tag: ophthalmic treatments

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.